ReviewCancers2026

The Adjuvant-Phase Dilemma After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC: Evidence and Response-Guided Strategies.

Jingyuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.